Rayssa Gabriely Duarte Torres

Rayssa Gabriely Duarte Torres

Auto-generated profile, based on publicly available information

Rayssa Gabriely Duarte Torres


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2024 in Non-coding RNA Research
Verified
Journal Article
Open access
HGHemerson Casado Gama
Hemerson Casado Gama
MAMariana A. Amorós
Mariana A. Amorós
MAMykaella Andrade de Araújo
Mykaella Andrade de Araújo
CSCongzhou M. Sha
Congzhou M. Sha
MVMirella P.S. Vieira
Mirella P.S. Vieira
MDMarcelo Duzzioni
Marcelo Duzzioni
The discovery of disease-specific biomarkers, such as microRNAs (miRNAs), holds the potential to transform the landscape of Amyotrophic Lateral Sclerosis (ALS) by facilitating timely diagnosis, monitoring treatment response, and accelerating drug discovery. Such advancement could ultimately improve the quality of life and survival rates for ALS patients. Despite more than a decade of research, no miRNA biomarker candidate has been translated into clinical practice. We conducted a systematic review and meta-analysis to quantitatively synthesize data from original studies that analyzed miRNA expression from liquid biopsies via PCR and compared them to healthy controls. Our analysis encompasses 807 miRNA observations from 31 studies, stratified according to their source tissue. We identified consistently dysregulated miRNAs in serum (hsa-miR-3665, -4530, -4745–5p, −206); blood (hsa-miR-338–3p, -183–5p); cerebrospinal fluid (hsa-miR-34a-3p); plasma (hsa-miR-206); and neural-enriched extracellular vesicles from plasma (hsa-miR-146a-5p, −151a-5p, −10b-5p, −29b-3p, and −4454). The meta-analyses provided further support for the upregulation of hsa-miR-206, hsa-miR-338–3p, hsa-miR-146a-5p and hsa-miR-151a-5p, and downregulation of hsa-miR-183–5p, hsa-miR-10b-5p, hsa-miR-29b-3p, and hsa-miR-4454 as consistent indicators of ALS across independent studies. Our findings provide valuable insights into the current understanding of miRNAs' dysregulated expression in ALS patients and on the researchers’ choices of methodology. This work contributes to the ongoing efforts towards discovering disease-specific biomarkers.

16 May 2025 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
YSYngrid Mickaelli Oliveira dos Santos
Yngrid Mickaelli Oliveira dos Santos
IMIgor Santana de Melo
Igor Santana de Melo
APAmanda Larissa Dias Pacheco
Amanda Larissa Dias Pacheco
MRMilenna Maria Jatoba Hasten Reiter
Milenna Maria Jatoba Hasten Reiter
MCMaisa de Araújo Costa
Maisa de Araújo Costa
Olagide Wagner de CastroOlagide Wagner de Castro
Olagide Wagner de Castro